“…Animal studies suggest that COX-2-derived vasodilatory prostaglandins play a more prominent role in arterial vasoregulation in females, 7 , 8 an effect that may be mediated by estrogen 9 , 10 and testosterone. 11 COX-2 inhibition in humans with uncomplicated type 1 diabetes abolished sex differences in the renal hemodynamic response to angiotensin II (AngII) challenge, suggesting an augmented female prostanoid-dependence and the possibility that prostaglandins contribute to renin-angiotensin-aldosterone system (RAAS)-mediated sex differences. 12 However, whether this same phenomenon occurs in the systemic vasculature in a healthy population is unknown.…”